Yüklüyor......
An Advanced Apralog with Increased in-vitro and in-vivo Activity toward Gram-negative Pathogens and Reduced ex-vivo Cochleotoxicity.
We describe the convergent synthesis of a 5-O-β-D-ribofuranosyl-based apramycin derivative (apralog) that displays significantly improved antibacterial activity over the parent apramycin against wild-type ESKAPE pathogens. In addition, the new apralog retains excellent antibacterial activity in the...
Kaydedildi:
| Yayımlandı: | ChemMedChem |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7855274/ https://ncbi.nlm.nih.gov/pubmed/33007139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.202000726 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|